Malaria Prevention Articles & Analysis
7 news found
Thanks to this deal, Imaxio will now focus on the commercialization of Spirolept®, its human vaccine indicated for the prevention of a professional infectious disease, and on the development of its vaccines pipeline, based on its proprietary technology IMX313. ...
Respectively submitted in 2005 and 2009, these initial patents compose the current portfolio of Imaxio and offer an international protection to the first generation of its antigen re-engineering technology, as well as to its tuberculosis vaccine candidate co-developed with the Jenner Institute at Oxford University Thus, the two recent notices significantly strengthen the intellectual property of ...
The Jenner Institute at Oxford University, together with partners Imaxio and GSK, has started a phase I clinical trial of a novel vaccine candidate aimed at blocking transmission of malaria. Around half the world’s population is at risk of malaria and the disease led to an estimated 584,000 deaths in 2013. ...
A new study commissioned by the International SOS Foundation and published by Prevent reveals the benefits of implementing pre-travel health checks and malaria prevention measures for business travellers and international assignees. ...
Biodiversity could play a key role in preventing future outbreaks of malaria in tropical forests, according to a new study. ...
Cuba has announced plans to build biolarvicide factories in Brazil and several African countries in a bid to tackle malaria and dengue fever. Biolarvicides are biological products that are added to water to kill mosquitoes at the larval stage. ...
Zinc micronutrient deficiency is a significant public health issue, causing 800,000 deaths overall and putting at risk more than two billion people due to ailments such as diarrhea, pneumonia and malaria. Many of these cases are preventable with a simple zinc supplement or through zinc-enhanced fertilizers. ...